Retailers Accuse Pharma Cos. Of Blocking Generic Bystolic

Law360 (November 23, 2020, 6:01 PM EST) -- Walgreens, Kroger and two other retail chains have filed an antitrust suit in New York federal court against a host of drugmakers including AbbVie and Allergan, accusing them of scheming to hold off generic forms of branded blood pressure drug Bystolic to jack up profits.

Even though a cheaper version of the drug has long been available, potentially saving money for retailers and consumers, the generic won't be stocked on pharmacy shelves until September under anti-competitive deals among the pharmaceutical companies, the retailers claim in their suit filed on Friday.

The complaint by Walgreen Co., the Kroger Co., Albertsons Cos. and H-E-B...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!